Back to search

Article

<i>In vivo</i> CRISPR-Cas gene editing with no detectable genome-wide off-target mutations

2018-02-27

Abstract excerpt

CRISPR-Cas genome-editing nucleases hold substantial promise for human therapeutics 1–5 but identifying unwanted off-target mutations remains an important requirement for clinical translation 6, 7 . For ex vivo therapeutic applications, previously published cell-based genome-wide methods provide potentially useful strategies to identify and quantify these off-target mutation sites 8–12 . However, a well-valida...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12974b0a-42dc-5b86-b984-8d80b6937590
DOI
10.1101/272724
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vivo</i> CRISPR-Cas gene editing with no detectable genome-wide off-target mutationsDOI 10.1101/272724
Select a neighboring publication to make it the new centre.